A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection

Gastroenterology

Volumn 141, Issue 1, 2011, Pages

  Knapp, Susanne ^a   Warshow, Usama ^b   Ho, K M Alexander ^a   Hegazy, Doha ^b   Little, Annmargaret ^c   Fowell, Andrew ^d   Alexander, Graeme ^e   Thursz, Mark ^a   Cramp, Matthew ^b   Khakoo, Salim I ^a,f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Genetics; Killer Cell Immunoglobulin Like Receptor; Liver Disease; Protective Mechanisms

Indexed keywords

HLA C ANTIGEN; INTERLEUKIN 28B; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3;

ADULT; ARTICLE; CONTROLLED STUDY; EXPOSURE; FEMALE; GENOTYPE; HEPATITIS C; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS RESOLVER; UNINFECTED INDIVIDUAL;

EID: 79959962743     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.04.005     Document Type: Article

References (27)

1. B. Rehermann Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence J Clin Invest 119 2009 1745 1754
2. A. Rauch, S. Gaudieri, and C. Thio Host genetic determinants of spontaneous hepatitis C clearance Pharmacogenomics 10 2009 1819 1837
3. D. Ge, J. Fellay, and A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
4. V. Suppiah, M. Moldovan, and G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy Nat Genet 41 2009 1100 1104
5. Y. Tanaka, N. Nishida, and M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
6. D.L. Thomas, C.L. Thio, and M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
7. A. Balagopal, D.L. Thomas, and C.L. Thio IL28B and the control of hepatitis C virus infection Gastroenterology 139 2010 1865 1876
8. S.I. Khakoo, C.L. Thio, and M.P. Martin HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874 (Pubitemid 39038423)
9. V. Romero, J. Azocar, and J. Zuniga Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome Mol Immunol 45 2008 2429 2436
10. S. Knapp, U. Warshow, and D. Hegazy Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus Hepatology 51 2010 1168 1175
11. J.R. Vidal-Castineira, A. Lopez-Vazquez, and R. Diaz-Pena Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection J Virol 84 2010 475 481
12. E. Mizukoshi, C. Eisenbach, and B.R. Edlin Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV J Infect Dis 198 2008 203 212 (Pubitemid 352019285)
13. P.H. Thurairajah, D. Hegazy, and S. Chokshi Hepatitis C virus (HCV)-specific T-cell responses in injection drug users with apparent resistance to HCV infection J Infect Dis 198 2008 1749 1755
14. L. Golden-Mason, A.L. Cox, and J.A. Randall Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro Hepatology 52 2010 1581 1589
15. D. Hegazy, P. Thurairajah, and M. Metzner Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection Clin Exp Immunol 152 2008 538 541 (Pubitemid 351661506)
16. A. Houldsworth, M. Metzner, and S. Rossol Polymorphisms in the IL-12B gene and outcome of HCV infection J Interferon Cytokine Res 25 2005 271 276 (Pubitemid 40664424)
17. M. Thursz, R. Yallop, and R. Goldin Influence of MHC class II genotype on outcome of infection with hepatitis C virus The HENCORE group. Hepatitis C European Network for Cooperative Research Lancet 354 1999 2119 2124 (Pubitemid 30008896)
18. S. Knapp, B.J. Hennig, and A.J. Frodsham Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection Immunogenetics 55 2003 362 369 (Pubitemid 37255487)
19. N. Gomez-Lozano, and C. Vilches Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update Tissue Antigens 59 2002 184 193 (Pubitemid 34666561)
20. P.P. Dunn, S.T. Cox, and A.M. Little Sequencing protocols for detection of HLA class I polymorphism Methods Mol Biol 210 2003 191 222
21. M. Cortina-Borja, A.D. Smith, and O. Combarros The synergy factor: a statistic to measure interactions in complex diseases BMC Res Notes 2 2009 105
22. M. Zeremski, M.A. Shu, and Q. Brown Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users J Viral Hepat 16 2009 10 20
23. B. Amadei, S. Urbani, and A. Cazaly Activation of natural killer cells during acute infection with hepatitis C virus Gastroenterology 138 2010 1536 1545
24. M. Li, X. Liu, and Y. Zhou Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses J Leukoc Biol 86 2009 23 32
25. M.D. Robek, B.S. Boyd, and F.V. Chisari Lambda interferon inhibits hepatitis B and C virus replication J Virol 79 2005 3851 3854 (Pubitemid 40327973)
26. M. Mordstein, E. Neugebauer, and V. Ditt Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections J Virol 84 2010 5670 5677
27. W. Abushahba, M. Balan, and I. Castaneda Antitumor activity of type I and type III interferons in BNL hepatoma model Cancer Immunol Immunother 59 2010 1059 1071